Clopidogrel Sandoz Euroopan unioni - englanti - EMA (European Medicines Agency)

clopidogrel sandoz

acino pharma gmbh - clopidogrel - peripheral vascular diseases; stroke; myocardial infarction - antithrombotic agents - clopidogrel is indicated in adults for the prevention of atherothrombotic events in:* patients suffering from myocardial infarction (from a few days until less than 35 days), ischaemic stroke (from 7 days until less than 6 months) or established peripheral arterial disease.for further information please refer to section 5.1.

Capecitabine Sandoz 150mg Film-Coated Tablet Kenia - englanti - Pharmacy and Poisons Board

capecitabine sandoz 150mg film-coated tablet

sandoz gmbh kundl biochemiestrasse 10 a-6250 - capecitabine - film-coated tablet - 150mg - capecitabine

Capecitabine Sandoz 500mg Film-Coated Tablet Kenia - englanti - Pharmacy and Poisons Board

capecitabine sandoz 500mg film-coated tablet

sandoz gmbh kundl biochemiestrasse 10 a-6250 - capecitabine - film-coated tablet - 500mg - capecitabine

AMOXICILLIN SANDOZ Irlanti - englanti - HPRA (Health Products Regulatory Authority)

amoxicillin sandoz

sandoz gmbh - amoxicillin trihydrate - capsules hard - 500 milligram

FINGOLIMOD SANDOZ fingolimod (as hydrochloride) 0.5 mg capsule blister pack Australia - englanti - Department of Health (Therapeutic Goods Administration)

fingolimod sandoz fingolimod (as hydrochloride) 0.5 mg capsule blister pack

sandoz pty ltd - fingolimod hydrochloride, quantity: 0.56 mg (equivalent: fingolimod, qty 0.5 mg) - capsule, hard - excipient ingredients: mannitol; iron oxide yellow; magnesium stearate; gelatin; titanium dioxide - fingolimod sandoz is indicated for the treatment of adult and paediatric patients of 10 years of age and above with relapsing forms of multiple sclerosis to reduce the frequency of relapses and to delay the progression of disability.